Stockreport

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

Orchestra BioMed Holdings, Inc. - Ordinary Shares  (OBIO) 
PDF $11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnoutsVivasure Medical Limited (“Viva [Read more]